导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -6.13% | 71/71 |
| 近一周 | -0.70% | 8/75 |
| 近一月 | -3.50% | 61/74 |
| 近一季 | -4.40% | 52/73 |
| 近半年 | -5.36% | 73/73 |
| 近一年 | -8.28% | 71/71 |
| 近两年 | 5.54% | 67/67 |
| 近三年 | 22.52% | 32/39 |
| 成立以来 | 46.33% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-4.46% 46/74 |
6.25% 59/74 |
-6.97% 74/74 |
- - |
| 2024 | 11.85% 47/75 |
4.45% 44/67 |
8.09% 15/72 |
2.92% 38/74 |
-3.74% 61/75 |
| 2023 | 18.30% 10/72 |
-6.13% 45/57 |
16.05% 9/64 |
-0.40% 8/68 |
9.03% 23/72 |
| 2022 | -5.53% 4/46 |
-6.16% 9/43 |
-8.80% 26/45 |
13.27% 1/45 |
-2.55% 35/46 |
| 2021 | 12.95% 6/43 |
5.04% 67/312 |
2.34% 180/328 |
7.75% 3/358 |
-2.49% 26/43 |
| 2020 | 2.43% 32/41 |
-26.64% 237/280 |
13.75% 137/295 |
8.62% 59/299 |
13.01% 73/305 |
| 2019 | - - |
- - |
6.00% 20/267 |
-1.10% 175/253 |
2.65% 173/266 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 国投瑞银白银期货(LOF)A | 1.7164 | 48.92% |
| 国投瑞银白银期货(LOF)C | 1.7017 | 48.76% |
| 泰信现代服务业混合 | 2.1670 | 38.91% |
| 创金合信全球医药生物股票发起(QDII)C | 1.7789 | 37.65% |
| 泰信发展主题混合 | 1.8890 | 37.48% |
| 永赢先锋半导体智选混合发起A | 1.2881 | 28.89% |
| 永赢先锋半导体智选混合发起C | 1.2863 | 28.72% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 嘉实资源精选股票A | 4.7401 | 21.68% |
| 华商致远回报混合C | 1.6720 | 21.39% |
| 宏利印度股票(QDII) VS. () |